What are the best medications for neuropathic pain?

Best Medications for Nerve Pain

Start with either gabapentin/pregabalin OR a tricyclic antidepressant (nortriptyline/desipramine) OR an SSNRI (duloxetine/venlafaxine) as first-line treatment for neuropathic pain. 1

First-Line Treatment Options

The evidence-based approach identifies four equally effective first-line medication classes:

1. Tricyclic Antidepressants (TCAs)

• Preferred agents: Nortriptyline or desipramine (secondary amines have fewer side effects than tertiary amines like amitriptyline) 1
• Advantages: Inexpensive, once-daily dosing, treats comorbid depression
• Critical caution: Obtain screening ECG for patients >40 years old; avoid or use cautiously in cardiac disease, limit to <100 mg/day 1
• Adequate trial: 6-8 weeks including 2 weeks at maximum tolerated dose 1
• Common pitfall: Anticholinergic effects (dry mouth, orthostatic hypotension, constipation, urinary retention) - mitigate by starting low, dosing at bedtime, and titrating slowly

2. SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

• Duloxetine: 60 mg once daily (start 30 mg for 1 week to reduce nausea) 1
  • Strong evidence for diabetic peripheral neuropathy
  • No ECG monitoring needed, no significant blood pressure changes
• Venlafaxine: 150-225 mg/day (requires 2-4 weeks titration) 1
  • Effective for diabetic neuropathy and mixed polyneuropathies
  • Warning: Monitor blood pressure, taper when discontinuing to avoid withdrawal syndrome

3. Calcium Channel α2-δ Ligands

• Gabapentin: Requires careful titration due to nonlinear pharmacokinetics; dose-adjust for renal insufficiency 1
• Pregabalin: More recent French guidelines downgraded to second-line due to lower efficacy in recent studies and misuse risk 2, 3
  • International guidelines still list as first-line 1
• Both cause dose-dependent dizziness and sedation - start low and titrate slowly

4. Topical Lidocaine

• Specifically for localized peripheral neuropathic pain only 1
• Can be used alone or combined with systemic first-line agents
• Strong evidence for postherpetic neuralgia 4

When to Use Opioids or Tramadol

Reserve for specific situations as first-line: 1

• Acute neuropathic pain
• Neuropathic cancer pain
• Episodic severe pain exacerbations
• When rapid pain relief needed during titration of other first-line medications

Otherwise, opioids and tramadol are second-line treatments.

Treatment Algorithm

Step 1: Choose one first-line medication based on:

• Comorbidities (depression → TCA or SSNRI; cardiac disease → avoid TCAs; renal disease → dose-adjust gabapentinoids)
• Pain distribution (localized → consider topical lidocaine)
• Side effect profile tolerance

Step 2: Reassess frequently

• Success (pain ≤3/10): Continue treatment
• Partial response (pain ≥4/10 after adequate trial): Add a second first-line medication from different class 1
• Failure (<30% pain reduction at target dose): Switch to alternative first-line medication

Step 3: If monotherapy and dual therapy fail → Consider second-line options:

• Tramadol 3, 5
• High-concentration capsaicin 8% patches (peripheral neuropathic pain only) 2, 3, 4
• Botulinum toxin A (focal peripheral neuropathic pain) 2, 3
• Combination therapy (e.g., gabapentin + morphine, nortriptyline + gabapentin showed superior efficacy) 1

Step 4: Third-line for refractory cases:

• Strong opioids (only when no alternatives) 2, 3, 5
• Spinal cord stimulation 2, 3
• High-frequency repetitive transcranial magnetic stimulation 2, 3
• Referral to pain specialist or multidisciplinary pain center 1

Critical Combination Therapy Evidence

Combination therapy often necessary since single agents provide only partial relief. Evidence supports: 1

• Gabapentin + extended-release morphine (better pain relief at lower doses of each)
• Nortriptyline + gabapentin (superior to either alone)
• Pregabalin + topical lidocaine

The combination approach allows lower doses of each medication, potentially reducing adverse effects while improving efficacy.

Important Caveats

• No single medication is universally effective 1
• Most medications provide only partial pain relief 1
• Realistic expectation: Target pain reduction to ≤3/10, not complete elimination 1
• Adequate trial duration matters: Don't abandon a medication prematurely (TCAs need 6-8 weeks) 1
• Recent negative trials in HIV-associated and chemotherapy-induced neuropathy suggest some conditions may be more refractory 1